Health DiagnosticsDiabetesDetectors, Sensors and MemsWearablesEnterprise SoftwareHardwareHealth Care
Description
DexCom, Inc. (Dexcom) operates as a medical device company. The company focuses on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes and metabolic health by patients, caregi…
Analysis
Beloved champion
DexCom, Inc. is a beloved champion: its quality is genuine, and the market already prices it as exceptional.
The price is expensive. You pay 34.6× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 14% yearly growth; analysts expect 22%. The price, in other words, assumes less than the experts do.
The trajectory is solid and the balance sheet is sturdy. The company scores 20/20 on our value-creation score: strong value creator.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202332
78
2023202420252026
All-time high
78
Jun 2026
All-time low
32
Jan 2023
Average rank
58
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
28
17
5
6
Price/Earnings
25
14
10
20
Price/Book
32
20
12
14
Dividend Yield
1
1
1
1
Value (overall)
16
26
4
5
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.